<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04719754</url>
  </required_header>
  <id_info>
    <org_study_id>VD-WHH</org_study_id>
    <nct_id>NCT04719754</nct_id>
  </id_info>
  <brief_title>Epidemiology of Abnormal Vaginal Discharge During Pregnancy</brief_title>
  <official_title>Epidemiology and Clinico-investigative Study of Abnormal Vaginal Discharge During Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vaginitis among women of childbearing age is well acknowledged as a public health concern due&#xD;
      to its high occurrence. Vulvovaginitis is a disorder of the vulva and/or vagina caused by&#xD;
      infection, inflammation, or changes in the flora.&#xD;
&#xD;
      There are many types of infections that affect the vagina, the most common three types of&#xD;
      infection: bacterial vaginosis, trichomoniasis, and candidiasis. Bacterial vaginosis is the&#xD;
      most common vaginal infection in women of reproductive age causing thin and milky vaginal&#xD;
      discharge with a fishy odor. Trichomoniasis causes a frothy, greenish-yellow discharge with a&#xD;
      foul smell.&#xD;
&#xD;
      Vaginal Candidiasis is one of the most common fungal infections of the female genital tract&#xD;
      and the second most common vaginal infection affecting women of reproductive age (after the&#xD;
      bacterial infection worldwide. It affects more than 75% of women at least once in their&#xD;
      lifetime, with approximately 50% of them also suffering a single recurrence.&#xD;
&#xD;
      About 75% of patients suffering from candidiasis are asymptomatic, but it may be symptomatic&#xD;
      with clinical picture characterized by itching, vaginal pain, vulvar burning sensation,&#xD;
      dyspareunia, dysuria and mildly unpleasant odor, erythema and vulvar edema, white-yellowish&#xD;
      plaques on the walls of the vagina and cervix and cheesy vaginal discharge. The risk of&#xD;
      vulvo-vaginal candidiasis increases by 30% during pregnancy also in pregnancy, the presence&#xD;
      of vaginitis is related to abortion, intrauterine infection, fetal growth retardation,&#xD;
      premature rupture of membranes, preterm birth, low birth weight, puerperal infection, and&#xD;
      other adverse pregnancy outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence of microorganism in the vaginal discharge during pregnancy.</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Vaginal Infection</condition>
  <arm_group>
    <arm_group_label>Pregnant women with abnormal vaginal discharge</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant women without abnormal vaginal discharge</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vaginal swab</intervention_name>
    <description>The other vaginal swab will be cultured on blood agar, chocolate agar, MacConkey agar and Sabourauds dextrose agar. The cultures will be incubated at 37ÂºC for 24-96 h or until the colonies appear.</description>
    <arm_group_label>Pregnant women with abnormal vaginal discharge</arm_group_label>
    <arm_group_label>Pregnant women without abnormal vaginal discharge</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At any gestational age&#xD;
&#xD;
          -  Age of patient: 19-40&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women in labor&#xD;
&#xD;
          -  Women with current vaginal bleeding&#xD;
&#xD;
          -  Women with current preterm rupture of membrane&#xD;
&#xD;
          -  Women immunocompromised women&#xD;
&#xD;
          -  Women patients who refused to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed K Ibrahim, MD</last_name>
    <role>Study Director</role>
    <affiliation>Woman's Health Hospital- Assiut university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Doaa Makarem, MSc</last_name>
    <phone>+201065312287</phone>
    <email>Doaamakarem5@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed Alaa Youssef, MD</last_name>
    <phone>01006184921</phone>
    <email>ahmedalaa11282@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Woman's Health Hospital - Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doaa K Makarem, MSc</last_name>
      <phone>+01065312287</phone>
      <email>Doaamakarem5@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 18, 2021</study_first_submitted>
  <study_first_submitted_qc>January 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Doaa Makarem Hassan</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaginal Discharge</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

